Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Valsartan and Hydrochlorothiazide Dispersible Tablets

Approval Number

国药准字H20110092

Company山东司邦得制药有限公司

Registration Date

December 23, 2020

Previous Approval Numbers

国药准字H20110092

Drug Information

Generic Name

缬沙坦氢氯噻嗪分散片

Brand Name

迈邦

Dosage Form

片剂

Strength

每片含缬沙坦80mg、氢氯噻嗪12.5mg。

Drug Type

化学药品

Registration Date

December 23, 2020

Company Information

Applicant Company

Company Name山东司邦得制药有限公司

Company Address

章丘市龙山镇龙湖路东

Manufacturing Company

Company Name山东司邦得制药有限公司

Company Address

章丘市龙山镇龙湖路东

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy